Du Jingchun, Wang Zhigao
Department of Clinical Immunology, Kingmed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou 510182, China.
Center for Regenerative Medicine, Heart Institute, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, 560 Channelside Drive, Tampa, FL 33602, USA.
Biomedicines. 2024 Jul 9;12(7):1525. doi: 10.3390/biomedicines12071525.
Receptor-interacting protein kinase 1 (RIPK1) plays a crucial role in controlling inflammation and cell death. Its function is tightly controlled through post-translational modifications, enabling its dynamic switch between promoting cell survival and triggering cell death. Phosphorylation of RIPK1 at various sites serves as a critical mechanism for regulating its activity, exerting either activating or inhibitory effects. Perturbations in RIPK1 phosphorylation status have profound implications for the development of severe inflammatory diseases in humans. This review explores the intricate regulation of RIPK1 phosphorylation and dephosphorylation and highlights the potential of targeting RIPK1 phosphorylation as a promising therapeutic strategy for mitigating human diseases.
受体相互作用蛋白激酶1(RIPK1)在控制炎症和细胞死亡中起关键作用。其功能通过翻译后修饰受到严格调控,使其能够在促进细胞存活和触发细胞死亡之间进行动态切换。RIPK1在不同位点的磷酸化是调节其活性的关键机制,具有激活或抑制作用。RIPK1磷酸化状态的紊乱对人类严重炎症性疾病的发展具有深远影响。本综述探讨了RIPK1磷酸化和去磷酸化的复杂调控,并强调了将RIPK1磷酸化作为减轻人类疾病的一种有前景的治疗策略进行靶向治疗的潜力。